BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:iCalendar-Ruby
BEGIN:VEVENT
LOCATION:Berlin\, Germany
SEQUENCE:0
DTEND:20100601T000000
DTSTART:20100529T000000
UID:2012-05-24T18:45:08-04:00_579336902@tcs4.inetu.net
DTSTAMP:20120524T184508
DESCRIPTION:\nAdvances in CRT and LV Reverse Remodeling in HeartFailure \nC
 ME (0.5 credits See website for details)\n\nFaculty: Gregg Fonarow\, MD\, M
 ichael R. Gold\, MD\, PhD\, and Helmut Klein\, MD\n\nLearn more about the u
 se of CRT devices in early-stage HF and its effects on prevention of diseas
 e progression. Learning objectives are:\n\n	-Discuss the CRT LV reverse rem
 odeling results from CARE-HF\, REVERSE\, and MADIT-CRT\n\n	-Describe the ro
 le these results will play in clinical practice\n\n(http://www.theheart.org
 /article/1036713.do) View Program On-line. \n\nProgram was released on Dece
 mber 22\, 2009 and is valid for credit through December 22\, 2010.\nA conti
 nuing education activity sponsored by Medscape(r) on theheart.org. \nSuppor
 ted by an independent educational grant from Medtronic\, Inc.\n\nSurvival w
 ith ICD in Heart Failure: "Real-World" Experience on Par with Trials \nCME 
 (0.25 credits See website for details)\n\nHeartwire CME Authors: Steve Stil
 es and D&eacute\;sir&eacute\;e Lie\, MD\, MSEd\n\nThis is a retrospective e
 xamination of data from two cardiac registries\, the OPTIMIZE-HF and the Ge
 t With the Guidelines-Heart Failure registries\, which were later merged\, 
 to compare mortality outcomes of ICD vs no ICD in older patients admitted f
 or heart failure.\n\n(http://www.cme.medscape.com/viewarticle/714241) View 
 Program On-Line. \n\nProgram was released on December 23\, 2009 and is vali
 d for credit through December 23\, 2010.\nA continuing education activity d
 eveloped and funded by Medscape(r).\n\nRisk Stratification in Hypertrophic 
 Cardiomyopathy: ICD Therapy \nCME (0.5 credits See website for details)\n\n
 Faculty: Eric N. Prystowsky\, MD and Mark Estes\, MD\n\nLearning objectives
  are:\n\n	-Describe the data supporting the rationale for the targeted use 
 of ICDs in cardiac arrhythmia patients\n\n	-Implement the current guideline
 s for the management of patients with cardiac arrhythmias\n\n	-Apply risk s
 tratification strategies to determine appropriate use of ICDs in arrhythmia
  management\n\n(http://www.theheart.org/article/1035315.do) View Program On
 -line. \n\nProgram was released on December 17\, 2009 and is valid for cred
 it through December 17\, 2010.\nA continuing education activityon theheart.
 org. \nSupported by an independent educational grant from Medtronic\, Inc.\
 n\nDES Comparisons: Insights from Late-term Follow-up \nCME (0.5 credits Se
 e website for details)\n\nFaculty: Spencer B. King\, III\, MD and David O. 
 Williams\, MD\n\nLearning objectives are:\n\n	-Apply clinical trial data on
  the safety and efficacy of DES to the management of patients undergoing pe
 rcutaneous coronary intervention\n\n	-Compare and contrast short- and long-
 term outcomes from various Drug Eluting Stent (DES) studies\n\n(http://www.
 theheart.org/article/1036489.do) View Program On-line. \n\nProgram was rele
 ased on December 22\, 2009 and is valid for credit through December 22\, 20
 10.\nA continuing education activity sponsored by Medscape(r) on theheart.o
 rg. \nSupported by an independent educational grant from Medtronic\, Daiich
 i Sankyo\, Inc.\, and Eli Lilly and Company.\n\nDual Antiplatelet Therapy: 
 Dueling Options in Real-World Practice \nCME (0.25 credits See website for 
 details)\n\nFaculty: Spencer B. King\, III\, MD\, Deepak L. Bhatt\, MD\, an
 d Ph. Gabriel Steg\, MD\n\nThis program is intended for physicians involved
  in the care of patients undergoing PCI for acute coronary syndrome. \nLear
 ning objectives include:\n\n	-Review the role of dual antiplatelet therapy 
 in patients undergoing PCI\n\n	-Apply recent data to the optimal management
  of antiplatelet therapy in patients undergoing revascularization\n\n(http:
 //www.theheart.org/article/1004303.do) View Program On-line. \n\nProgram wa
 s released on September 30\, 2009 and is valid for credit through September
  30\, 2010.\nA continuing education activity sponsored by Medscape(r) on th
 eheart.org. \nSupported by an independent educational grant from Medtronic\
 , Daiichi Sankyo\, Inc.\, and Eli Lilly and Company.
SUMMARY:Heart Failure 2010
END:VEVENT
END:VCALENDAR